ArticleNature medicine2024

Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results.

Stephen J Bagley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.